Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2023
2023
2016
2022
2021 - 2022
Established and managed the coparion life science division focusing on seed to Series B investment opportunities in the therapeutics, medical technology, diagnostics, and digital health space Led all life science related investment activities from deal sourcing to scientific and commercial evaluation, formal due diligence, contract negotiations, and investment execution Supported all nine life science portfolio companies (17 financing rounds, €500M+ cumulated post-money valuation) as Board Director or Board Observer Established a life science focused investment team and led one Associate and several interns Represented coparion at life science conferences and partnering meetings and created a network of European co-investors (VCs, corporate VCs, Family Offices and Business Angles) and global pharma companies
2021 - 2021
2016 - 2021
2018
2018
2020 - 2024
2020 - 2024
2022 - 2023
2022 - 2023
2021 - 2022
2021 - 2022
2021 - 2022
2021 - 2022
2020 - 2022
2020 - 2022
2019 - 2022
2019 - 2022
2019 - 2022
2019 - 2022